News

Shareholder Alert on Class Action for Cardlytics, Inc. CDLX

Shareholder Alert on Class Action for Cardlytics, Inc. CDLX

Important Shareholder Update Regarding Cardlytics, Inc.

The Gross Law Firm takes this opportunity to inform shareholders of Cardlytics, Inc. (NASDAQ: CDLX) about significant developments concerning a potential class action lawsuit.

Class Action Lawsuit Details

Shareholders who purchased shares during the specific timeframe are encouraged to reach out to the Gross Law Firm. Participating as a lead plaintiff is not a requirement to gain any recovery, allowing all shareholders to be part of the process without additional obligations.

Class Period Information

The class period extends from March 14, 2024, to August 7, 2024. This is the time frame in which potential deceptive practices may have influenced the company’s stock performance.

Allegations Against Cardlytics, Inc.

The allegations claim that throughout the class period, defendants provided misleading statements about the company's business health. Reports indicated increasing consumer engagement that was supposedly not matched by corresponding billing increases. This discrepancy suggested a looming threat of revenue stagnation or decline, ultimately affecting shareholder investments adversely.

Upcoming Deadlines for Shareholders

It is crucial for shareholders to act promptly, as the deadline to register for this class action is set for March 25, 2025. Participating now ensures you remain informed and involved in the legal proceedings.

Next Steps for Interested Shareholders

Upon registration, shareholders who purchased shares within the outlined class period will gain access to continuous updates regarding the case via a monitoring system. This service comes at no additional cost.

Why Choose the Gross Law Firm?

The Gross Law Firm is esteemed for its commitment to safeguarding investors' rights. By pursuing legal action against companies engaging in unethical practices, the firm strives to ensure accountability and transparency in the business world. They are devoted to advocating for those who have encountered losses due to misleading corporate communications.

Contact Information

For more inquiries or to register, please reach out to the Gross Law Firm:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903

Frequently Asked Questions

What is a lead plaintiff in a class action?

A lead plaintiff is an individual or entity that represents the interests of the whole class in a class action lawsuit.

How can I participate in the Cardlytics lawsuit?

Shareholders who purchased during the class period can register with the Gross Law Firm to join in the class action.

What allegations are being made against Cardlytics?

The lawsuit alleges that Cardlytics provided misleading statements about its consumer engagement and revenue forecasts.

When is the deadline to register for the lawsuit?

The final date to register as a lead plaintiff is March 25, 2025. Ensure to register before this date to participate.

Why is the Gross Law Firm recognized?

The Gross Law Firm has a reputation for championing the rights of investors and pursuing accountability from companies for unethical practices.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Eli Lilly's Pirtobrutinib Shows Promising Results in CLL Trials

Updated Category News Views 158

Pirtobrutinib's Efficacy in Chronic Lymphocytic Leukemia Studies Eli Lilly and Company (NYSE: LLY) made notable advancements in chronic lymphocytic leukemia (CLL) research with their drug, pirtobrutinib. The recent study, known as BRUIN CLL-321, demonstrated that pirtobrutinib significantly reduced the risk of disease progression or death by 46% compared to previous...

Continue Reading
Exploring Axon Enterprise's Options Trading Dynamics

Updated Category News Views 173

Investors' Insights on Axon Enterprise In the ever-evolving world of stock market investments, insights from institutional and wealthy individual investors can carry significant weight. Recently, there has been a noticeable bullish stance on Axon Enterprise (NASDAQ: AXON), raising curiosity among retail traders about potential future movements. Unusual Options Activity...

Continue Reading
Aventis Energy Releases Technical Report on Corvo Project

Updated Category News Views 143

Aventis Energy Files NI 43-101 Technical Report on Corvo Project Aventis Energy Inc. (“Aventis” or the “Company”) (CNSX: AVE | Frankfurt: C0O0 | Other OTC: VBAMF) is excited to announce that its partner, Standard Uranium Ltd., has filed a technical report detailing findings and exploration data from the Corvo Project. This report, titled "Technical Report on the...

Continue Reading
Drucker + Falk Celebrates Community Commitment Through Cleanup Events

Updated Category News Views 108

Drucker + Falk's Dedication to Community Engagement Drucker + Falk, a prominent name in multifamily property management, has made remarkable strides in community involvement through its annual clean-up initiatives. This year, they marked the third consecutive clean-up campaign aimed at enhancing local environments, aligning their efforts with the mission of Keep America...

Continue Reading
Exploring the Future of Mental Health: The Wholeness Center

Updated Category News Views 96

Revolutionizing Mental Health with Integrative Approaches The Wholeness Center has gained state approval to offer legal psilocybin-assisted therapy, marking a significant milestone as the sole licensed healing center in Northern Colorado. This innovative facility combines the realms of psychedelic therapy with integrative psychiatry, aiming to provide comprehensive mental...

Continue Reading